0001127602-11-015280.txt : 20110505 0001127602-11-015280.hdr.sgml : 20110505 20110505164152 ACCESSION NUMBER: 0001127602-11-015280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110505 FILED AS OF DATE: 20110505 DATE AS OF CHANGE: 20110505 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DWEK RAYMOND CENTRAL INDEX KEY: 0001231617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 11815236 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0303 4 2011-05-05 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231617 DWEK RAYMOND C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 Common Stock 2011-05-05 2011-05-05 4 M 0 1667 6.045 A 1667 D Common Stock 2011-05-05 2011-05-05 4 S 0 1667 66.61 D 0 D Stock Options 6.045 2011-05-05 2011-05-05 4 M 0 1667 0 D 2003-03-15 2012-03-15 Common Stock 1667 0 D Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. /s/ John S. Hess, Jr. under Power of Attorney 2011-05-05